BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10940617)

  • 1. Polycystic ovary syndrome in patients with focal epilepsy: a study in 93 women.
    Bauer J; Jarre A; Klingmüller D; Elger CE
    Epilepsy Res; 2000 Sep; 41(2):163-7. PubMed ID: 10940617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
    Hu X; Wang J; Dong W; Fang Q; Hu L; Liu C
    Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
    J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
    Isojärvi JI; Laatikainen TJ; Pakarinen AJ; Juntunen KT; Myllylä VV
    N Engl J Med; 1993 Nov; 329(19):1383-8. PubMed ID: 8413434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome in patients with epilepsy: a study in 102 Chinese women.
    Zhou JQ; Zhou LM; Chen LJ; Han JD; Wang Q; Fang ZY; Chen ZY; Ling S
    Seizure; 2012 Nov; 21(9):729-33. PubMed ID: 22944116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and endocrine disorders in women taking valproate for epilepsy.
    Isojärvi JI; Laatikainen TJ; Knip M; Pakarinen AJ; Juntunen KT; Myllylä VV
    Ann Neurol; 1996 May; 39(5):579-84. PubMed ID: 8619542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered ovarian function and cardiovascular risk factors in valproate-treated women.
    Isojärvi JI; Taubøll E; Pakarinen AJ; van Parys J; Rättyä J; Harbo HF; Dale PO; Fauser BC; Gjerstad L; Koivunen R; Knip M; Tapanainen JS
    Am J Med; 2001 Sep; 111(4):290-6. PubMed ID: 11566460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.
    Stephen LJ; Kwan P; Shapiro D; Dominiczak M; Brodie MJ
    Epilepsia; 2001 Aug; 42(8):1002-6. PubMed ID: 11554885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy.
    Betts T; Yarrow H; Dutton N; Greenhill L; Rolfe T
    Seizure; 2003 Sep; 12(6):323-9. PubMed ID: 12915077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluate the effects of antiepileptic drugs on reproductive endocrine system in newly diagnosed female epileptic patients receiving either Valproate or Lamotrigine monotherapy: A prospective study.
    Sidhu HS; Srinivasa R; Sadhotra A
    Epilepsy Res; 2018 Jan; 139():20-27. PubMed ID: 29144993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.
    Isojärvi JI; Rättyä J; Myllylä VV; Knip M; Koivunen R; Pakarinen AJ; Tekay A; Tapanainen JS
    Ann Neurol; 1998 Apr; 43(4):446-51. PubMed ID: 9546324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy.
    El-Khayat HA; Abd El-Basset FZ; Tomoum HY; Tohamy SM; Zaky AA; Mohamed MS; Hakky SM; El Barbary NS; Nassef NM
    Epilepsia; 2004 Sep; 45(9):1106-15. PubMed ID: 15329076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate, hyperandrogenism, and polycystic ovaries: a report of 3 cases.
    Isojarvi JI; Tapanainen JS
    Arch Neurol; 2000 Jul; 57(7):1064-8. PubMed ID: 10891991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizure type, antiepileptic drugs, and reproductive endocrine dysfunction in Indian women with epilepsy: a cross-sectional study.
    Sahota P; Prabhakar S; Kharbanda PS; Bhansali A; Jain V; Das CP; Modi M
    Epilepsia; 2008 Dec; 49(12):2069-77. PubMed ID: 18503558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate.
    Luef G; Abraham I; Trinka E; Alge A; Windisch J; Daxenbichler G; Unterberger I; Seppi K; Lechleitner M; Krämer G; Bauer G
    Epilepsy Res; 2002 Jan; 48(1-2):91-102. PubMed ID: 11823113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term reproductive endocrine health in young women with epilepsy during puberty.
    Mikkonen K; Vainionpää LK; Pakarinen AJ; Knip M; Järvelä IY; Tapanainen JS; Isojärvi JI
    Neurology; 2004 Feb; 62(3):445-50. PubMed ID: 14872028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epilepsy therapy: issues for women and men.
    Bauer J
    Curr Opin Neurol; 2001 Apr; 14(2):199-202. PubMed ID: 11262736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the association between valproate and polycystic ovary syndrome.
    Genton P; Bauer J; Duncan S; Taylor AE; Balen AH; Eberle A; Pedersen B; Salas-Puig X; Sauer MV
    Epilepsia; 2001 Mar; 42(3):295-304. PubMed ID: 11442143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy.
    Murialdo G; Galimberti CA; Magri F; Sampaolo P; Copello F; Gianelli MV; Gazzerro E; Rollero A; Deagatone C; Manni R; Ferrari E; Polleri A; Tartara A
    J Endocrinol Invest; 1997 Oct; 20(9):519-26. PubMed ID: 9413805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.